Acadia Files for $86M IPO

San Diego-based Acadia Pharmaceuticals ( has filed for a $86M IPO on the Nasdaq. The company develops small molecule drug candidates using a chemical-genomics platform. The company is backed by Oxford Bioscience Partners, Orbimed Advisors, Federated Kaufmann Fund, Hambrecht & Quist, ABN AMRO, Carnegie Fund, and Dansk Kapitalanlaeg Aktieselskab. More information »